Suppr超能文献

美国成年人中使用大麻与心血管结局的关联。

Association of Cannabis Use With Cardiovascular Outcomes Among US Adults.

机构信息

Center for Tobacco Control Research & Education University of California San Francisco CA USA.

Mongan Institute Health Policy Research Center, Massachusetts General Hospital Boston MA USA.

出版信息

J Am Heart Assoc. 2024 Mar 5;13(5):e030178. doi: 10.1161/JAHA.123.030178. Epub 2024 Feb 28.

Abstract

BACKGROUND

We examined the association between cannabis use and cardiovascular outcomes among the general population, among never-tobacco smokers, and among younger individuals.

METHODS AND RESULTS

This is a population-based, cross-sectional study of 2016 to 2020 data from the Behavioral Risk Factor Surveillance Survey from 27 American states and 2 territories. We assessed the association of cannabis use (number of days of cannabis use in the past 30 days) with self-reported cardiovascular outcomes (coronary heart disease, myocardial infarction, stroke, and a composite measure of all 3) in multivariable regression models, adjusting for tobacco use and other characteristics in adults 18 to 74 years old. We repeated this analysis among nontobacco smokers, and among men <55 years old and women <65 years old who are at risk of premature cardiovascular disease. Among the 434 104 respondents, the prevalence of daily and nondaily cannabis use was 4% and 7.1%, respectively. The adjusted odds ratio (aOR) for the association of daily cannabis use and coronary heart disease, myocardial infarction, stroke, and the composite outcome (coronary heart disease, myocardial infarction, and stroke) was 1.16 (95% CI, 0.98-1.38), 1.25 (95% CI, 1.07-1.46), 1.42 (95% CI, 1.20-1.68), and 1.28 (95% CI, 1.13-1.44), respectively, with proportionally lower log odds for days of use between 0 and 30 days per month. Among never-tobacco smokers, daily cannabis use was also associated with myocardial infarction (aOR, 1.49 [95% CI, 1.03-2.15]), stroke (aOR, 2.16 [95% CI, 1.43-3.25]), and the composite of coronary heart disease, myocardial infarction, and stroke (aOR, 1.77 [95% CI, 1.31-2.40]). Relationships between cannabis use and cardiovascular outcomes were similar for men <55 years old and women <65 years old.

CONCLUSIONS

Cannabis use is associated with adverse cardiovascular outcomes, with heavier use (more days per month) associated with higher odds of adverse outcomes.

摘要

背景

我们研究了普通人群、从不吸烟人群和年轻人群中,大麻使用与心血管结局之间的关联。

方法和结果

这是一项基于人群的横断面研究,使用了 2016 年至 2020 年来自美国 27 个州和 2 个地区的行为风险因素监测调查的数据。我们在多变量回归模型中评估了大麻使用(过去 30 天内大麻使用天数)与自我报告的心血管结局(冠心病、心肌梗死、中风和所有 3 种结局的综合指标)之间的关联,调整了烟草使用和其他特征在 18 至 74 岁的成年人中。我们在从不吸烟的人群中重复了这一分析,并在有发生心血管疾病风险的男性<55 岁和女性<65 岁的人群中进行了重复分析。在 434104 名受访者中,每日和非每日大麻使用者的比例分别为 4%和 7.1%。每日大麻使用与冠心病、心肌梗死、中风和综合结局(冠心病、心肌梗死和中风)的关联的调整比值比(aOR)分别为 1.16(95%可信区间,0.98-1.38)、1.25(95%可信区间,1.07-1.46)、1.42(95%可信区间,1.20-1.68)和 1.28(95%可信区间,1.13-1.44),随着每月使用天数在 0 至 30 天之间的比例下降,对数优势呈递减趋势。在从不吸烟的人群中,每日大麻使用也与心肌梗死(aOR,1.49[95%可信区间,1.03-2.15])、中风(aOR,2.16[95%可信区间,1.43-3.25])和冠心病、心肌梗死和中风的综合结局(aOR,1.77[95%可信区间,1.31-2.40])相关。在男性<55 岁和女性<65 岁的人群中,大麻使用与心血管结局之间的关系相似。

结论

大麻使用与不良心血管结局相关,使用量越大(每月使用天数越多),不良结局的可能性就越高。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f4d/10944074/3db6999a73a4/JAH3-13-e030178-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验